Galt Associates (Sterling, VA) has brought together the original Halo web-based safety research and monitoring environment with its dsNavigator search engine for a new and improved Halo platform. Featuring streamlined yet powerful querying capabilities, the platform offers ready access to a vast array of information sources-including FDA and WHO datasets-while a sophisticated interface gives safety professionals automated tools and an intuitive way to manage and analyze data.
Galt Associates (Sterling, VA) has brought together the original Halo web-based safety research and monitoring environment with its dsNavigator search engine for a new and improved Halo platform. Featuring streamlined yet powerful querying capabilities, the platform offers ready access to a vast array of information sources—including FDA and WHO datasets—while a sophisticated interface gives safety professionals automated tools and an intuitive way to manage and analyze data.
Haloâ¢
By using both data mining and traditional signaling methods, the new Halo allows researchers to thoroughly profile drugs and signal unexpected events proactively. Users define their own optimal search variables and can manipulate multiple output panels in real time. The graphical interface translates data from multiple internal and external sources into one common format, allowing for easier, more seamless investigation. An open platform and modular architecture allow users to customize extensions.
With Halo, Galt has created an integrated "intelligence" center that supports the safety monitoring and analysis needs of any company.
Galt Associates, (703) 547-3388, www.DrugSafety.com
ClinPhone (Princeton, NJ) has polished up the TrialWorks clinical trial management software (CTMS) it purchased from TrialTrac in 2004. TrialWorks now offers two-way integration with IVR/IWR in version 4.4.
TrialWorks⢠4.4
Let's say a user has just entered a subject visit into ClinPhone's interactive voice or Web response services. Previously, that information had to be entered again into the separate TrialWorks CTMS system in order for both systems to be fully updated. But now one system can instant-message the other and—zip!—the transaction is updated on the receiving end.
Users can also send site certification or qualification data, blast out study alerts, generate lots of new reports, and utilize expanded mail merge options.
Of course, TrialWorks still offers all the excellent database management features of previous editions. The system is 21 CFR 11 compliant. With version 4.4 it has become more user-friendly, intuitive and flexible, and it's done so by discussing workflow and practical needs directly with their clients.
In most cases, TrialWorks can be implemented in just two days.
ClinPhone, (609) 524-4100, www.clinphone.com or www.clinicaltrialsoftware.com
Medidata Solutions (New York, NY) has overcome one of the biggest obstacles in e-clinical trials: ensuring users can adopt new technologies. Their newest release—Rave 5.4—is a data capture and management software package that's easy to use and deploy, and allows for local lab data integration and more efficient system administration. It also lets users work off-line for even higher site adoption and increased efficiency.
Medidata Rave 5.4
Because it provides early visibility into critical data, user-friendly Rave also helps drive better decision making and lower overall risk for trial sponsors. With cost and pipeline pressures on the rise, the speedy delivery of innovations to market and the need for greater value for cost become critical factors. Rave addresses those needs by automating, streamlining and accelerating the flow of information. Among its enhancements are multiple subject views in real time, enhanced report administration, integrated dictionary coding, and translation tools.
Companies looking to improve their efficiencies and lower costs should find Rave's improved functionality appealing.
Medidata Solutions, (212) 918-1800, www.medidatasolutions.com
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Obe-Cel Achieves High Response Rates, Durable Outcomes in r/r B-Cell Acute Lymphoblastic Leukemia
December 3rd 2024CAR T-cell therapy obecabtagene autoleucel produced high response rates, durable outcomes, and low toxicity in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia, especially benefiting those with low-to-intermediate bone marrow burden.